Abstract:Introduction: Image-guided renal mass biopsy is gaining increased diagnostic acceptance, but there are limited data concerning the safety and diagnostic yield of biopsy for small renal masses (≤4 cm). This study evaluated the safety, diagnostic yield, and management after image-guided percutaneous biopsy for small renal masses. Methods: A retrospective IRB-approved study was conducted on patients who underwent renal mass biopsy for histopathologic diagnosis at a single center from 2015 to 2021. Patients with a prior history of malignancy or a renal mass >4 cm were excluded. Descriptive statistics were used to summarize patient demographics, tumor size, the imaging modality used for biopsy, procedure details, complications, pathological diagnosis, and post-biopsy management. A biopsy was considered successful when the specimen was sufficient for diagnosis without need for a repeat biopsy. Complications were graded according to the SIR classification of adverse events. A chi-squared test (significance level set at p ≤ 0.05) was used to compare the success rate of biopsies in different lesion size groups. Results: A total of 167 patients met the inclusion criteria. The median age was 65 years (range: 26–87) and 51% were male. The median renal mass size was 2.6 cm (range: one–four). Ultrasound was solely employed in 60% of procedures, CT in 33%, a combination of US/CT in 6%, and MRI in one case. With on-site cytopathology, the median number of specimens obtained per procedure was four (range: one–nine). The overall complication rate was 5%. Grade A complications were seen in 4% (n = 7), consisting of perinephric hematoma (n = 6) and retroperitoneal hematoma (n = 1). There was one grade B complication (0.5%; pain) and one grade D complication (0.5%; pyelonephritis). There was no patient mortality within 30 days post-biopsy. Biopsy was successful in 88% of cases. A sub-group analysis showed a success rate of 85% in tumors <3 cm and 93% in tumors ≥3 cm (p = 0.01). Pathological diagnoses included renal cell carcinoma (65%), oncocytoma (18%), clear cell papillary renal cell tumors (9%), angiomyolipoma (4%), xanthogranulomatous pyelonephritis (1%), lymphoma (1%), high-grade papillary urothelial carcinoma (1%), and metanephric adenoma (1%), revealing benign diagnosis in 30% of cases. The most common treatment was surgery (40%), followed by percutaneous cryoablation (22%). In total, 37% of patients were managed conservatively, and one patient received chemotherapy. Conclusion: This study demonstrates the safety and diagnostic efficacy of image-guided biopsy of small renal masses. The diagnostic yield was significantly higher for masses 3–4 cm in size compared to those <3 cm. The biopsy results showed a high percentage of benign diagnoses and informed treatment decisions in most patients.

Diagnosis of renal cell carcinoma subtype and nuclear grade on percutaneous biopsy

Individualized Renal Mass Biopsy Strategy for Chinese Patients with Different Subtypes and Necrosis Area

Analysis of diagnosis and treatment of 109 cases with renal cell carcinoma

Accuracy and safety of ultrasound-guided percutaneous needle core biopsy of renal masses: A single center experience in China.

[Percutaneous biopsy of the renal masses under ultrasound: a single-center 14 years experience].

[Diagnosis and Treatment of Cystic Renal Cell Carcinoma: a Report of 14 Cases].

Accuracy of Percutaneous Core Biopsy in the Diagnosis of Small Renal Masses (≤ 4.0 cm): A Meta-analysis.

Diagnostic accuracy and clinical impact of renal biopsy cytology

Evaluation of imaging-guided fine-needle percutaneous biopsy of renal masses

Diagnostic accuracy and clinical impact of imaging-guided needle biopsy of renal masses. Retrospective analysis on 150 cases

The Accuracy of Multidetector Computed Tomography for Preoperative Staging of Renal Cell Carcinoma

Clinical Analysis of Cystic Renal Cell Carcinoma : a Report of 67 Cases

Research on the Application Value of Ultrasound-guided Biopsy in the Diagnosis of Peripheral Lung Lesions

Evaluation of the accuracy of biopsy Gleason score as predictors of histological grading of prostate cancer specimens

Computed Tomography Radiomics for Predicting Pathological Grade of Renal Cell Carcinoma

Diagnostic Value of Preoperative Needle Biopsy for Tumor Grading Assessment in Hepatocellular Carcinoma

Use of RENAL Nephrometry Scores for Predicting Tumor Upgrading Between Core Biopsies and Surgical Specimens A Prospective Ex Vivo Study

Comparison of radiographic and pathologic sizes of renal tumors.

Clinical analysis of renal cell carcinoma:report of 271 cases

[Ureteroscope Can Assist Risk Stratification in Upper Tract Urothelial Carcinoma].

Safety and Diagnostic Efficacy of Image-Guided Biopsy of Small Renal Masses